For: | Wang L, Li HG, Xia ZS, Wen JM, Lv J. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma. World J Gastroenterol 2011; 17(34): 3933-3940 [PMID: 22025882 DOI: 10.3748/wjg.v17.i34.3933] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i34/3933.htm |
Number | Citing Articles |
1 |
Yajing Zhang, Senyu Wang, Songtao Han, Yangchun Feng. Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.844794
|
2 |
Patrícia Kimáková, Peter Solár, Zuzana Solárová, Radovan Komel, Nataša Debeljak. Erythropoietin and Its Angiogenic Activity. International Journal of Molecular Sciences 2017; 18(7): 1519 doi: 10.3390/ijms18071519
|
3 |
Toshimitsu Irei, Masahiro Tanemura, Masashi Inoue, Yuichi Hiyama, Hirotaka Kouno, Hiroshi Kohno, Kazuya Kuraoka, Kiyomi Taniyama, Yukinobu Yoshikawa, Wataru Kamiike. A Case of Erythropoietin Producing a Large Hepatocellular Carcinoma with Advanced Erythrocytosis. The Japanese Journal of Gastroenterological Surgery 2014; 47(1): 18 doi: 10.5833/jjgs.2013.0069
|
4 |
AGATA PONIEWIERSKA-BARAN, MALWINA SUSZYNSKA, WENYUE SUN, AHMED ABDELBASET-ISMAIL, GABRIELA SCHNEIDER, FREDERIC G. BARR, MARIUSZ Z. RATAJCZAK. Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications. International Journal of Oncology 2015; 47(5): 1989 doi: 10.3892/ijo.2015.3184
|
5 |
G. Liu, D.Z. Li, C.S. Jiang, W. Wang. Transduction motif analysis of gastric cancer based on a human signaling network. Brazilian Journal of Medical and Biological Research 2014; 47(5): 369 doi: 10.1590/1414-431X20143527
|
6 |
Jaime L. Shaw, Carrie M. Nielson, Joseph K. Park, Andrea Marongiu, Gerald A. Soff. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. European Journal of Haematology 2021; 106(5): 662 doi: 10.1111/ejh.13595
|
7 |
Lin Wang, Hai-Gang Li, Jian-Ming Wen, Ting-Sheng Peng, Hong Zeng, Ling-Yun Wang. Expression of CD44v3, Erythropoietin and VEGF-C in Gastric Adenocarcinomas: Correlations with Clinicopathological Features. Tumori Journal 2014; 100(3): 321 doi: 10.1177/1578.17216
|
8 |
Sunila Pradeep, Jie Huang, Edna M. Mora, Alpa M. Nick, Min Soon Cho, Sherry Y. Wu, Kyunghee Noh, Chad V. Pecot, Rajesha Rupaimoole, Martin A. Stein, Stephan Brock, Yunfei Wen, Chiyi Xiong, Kshipra Gharpure, Jean M. Hansen, Archana S. Nagaraja, Rebecca A. Previs, Pablo Vivas-Mejia, Hee Dong Han, Wei Hu, Lingegowda S. Mangala, Behrouz Zand, Loren J. Stagg, John E. Ladbury, Bulent Ozpolat, S. Neslihan Alpay, Masato Nishimura, Rebecca L. Stone, Koji Matsuo, Guillermo N. Armaiz-Peña, Heather J. Dalton, Christopher Danes, Blake Goodman, Cristian Rodriguez-Aguayo, Carola Kruger, Armin Schneider, Shyon Haghpeykar, Padmavathi Jaladurgam, Mien-Chie Hung, Robert L. Coleman, Jinsong Liu, Chun Li, Diana Urbauer, Gabriel Lopez-Berestein, David B. Jackson, Anil K. Sood. Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell 2015; 28(5): 610 doi: 10.1016/j.ccell.2015.09.008
|
9 |
Nataša Debeljak, Peter Solár, Arthur J. Sytkowski. Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00563
|
10 |
Chongyang Ma, Fafeng Cheng, Xueqian Wang, Changming Zhai, Wenchao Yue, Yajun Lian, Qingguo Wang. Erythropoietin Pathway: A Potential Target for the Treatment of Depression. International Journal of Molecular Sciences 2016; 17(5): 677 doi: 10.3390/ijms17050677
|
11 |
Yajing Zhang, Yousen Zhu, Senyu Wang, Yang chun Feng, Hui Li. Erythropoietin receptor is a risk factor for prognosis: A potential biomarker in lung adenocarcinoma. Pathology - Research and Practice 2023; 251: 154891 doi: 10.1016/j.prp.2023.154891
|
12 |
Domenico Ribatti, Roberto Tamma. Hematopoietic growth factors and tumor angiogenesis. Cancer Letters 2019; : 47 doi: 10.1016/j.canlet.2018.10.008
|
13 |
Keiji Hirai, Shohei Kaneko, Saori Minato, Katsunori Yanai, Momoko Hirata, Taisuke Kitano, Kiyonori Ito, Yuichiro Ueda, Susumu Ookawara, Yoshiyuki Morishita. Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1071342
|
14 |
JÁN KRIŠKA, PETER SOLÁR, LENKA VARINSKÁ, ZUZANA SOLÁROVÁ, PATRÍCIA KIMÁKOVÁ, JÁN MOJŽIŠ, PETER FEDOROČKO, ARTHUR J. SYTKOWSKI. Human erythropoietin increases the pro-angiogenic potential of A2780 ovarian adenocarcinoma cells under hypoxic conditions. Oncology Reports 2013; 30(3): 1455 doi: 10.3892/or.2013.2566
|
15 |
Aurelia Lamanuzzi, Ilaria Saltarella, Arianna Ferrucci, Roberto Ria, Simona Ruggieri, Vito Racanelli, Luigia Rao, Tiziana Annese, Beatrice Nico, Angelo Vacca, Domenico Ribatti. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients. Oncotarget 2016; 7(12): 14510 doi: 10.18632/oncotarget.7587
|
16 |
Xiaoqing Zhuang, Dan Zhao, Pengfei Yang, Yingqin Jia, Rui Liang, Qian Zhao, Chunlei Han, Joseph M. Kinsella, Ruilong Sheng, Juan Li. 99mTc‐labeled rHuEpo for imaging of the erythropoietin receptor in tumors. Journal of Labelled Compounds and Radiopharmaceuticals 2018; 61(2): 77 doi: 10.1002/jlcr.3586
|
17 |
Weiling Hu, Yu Zhang, Zhinong Jiang, Lan Wang, Jun Li, Shujie Chen, Ning Dai, Jianmin Si. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer. Tumor Biology 2016; 37(8): 11523 doi: 10.1007/s13277-016-5053-7
|